CONTEXT: Elevated homocysteine is a strong risk factor for osteoporotic fractures among elders, yet it may be a marker for low B-vitamin status. OBJECTIVE: Our objective was to examine the associations of plasma concentrations of folate, vitamin B12, vitamin B6, and homocysteine with bone loss and hip fracture risk in elderly men and women. DESIGN: This was a longitudinal follow-up study of the Framingham Osteoporosis Study. SETTING: Community dwelling residents of Framingham, MA, were included in the study. PARTICIPANTS: A total of 1002 men and women (mean age 75 yr) was included in the study. MAIN OUTCOME MEASURES: Baseline (1987-1989) blood samples were used to categorize participants into plasma B-vitamin (normal, low, deficient) and homocysteine (normal, high) groups. Femoral neck bone mineral density (BMD) measured at baseline and 4-yr follow-up was used to calculate annual percent BMD change. Incident hip fracture was assessed from baseline through 2003. RESULTS: Multivariable-adjusted mean bone loss was inversely associated with vitamin B6 (P for trend 0.01). Vitamins B12 and B6 were inversely associated with hip fracture risk (all P for trend < 0.05), yet associations were somewhat attenuated and not significant after controlling for baseline BMD, serum vitamin D, and homocysteine. Participants with high homocysteine (>14 micromol/liter) had approximately 70% higher hip fracture risk after adjusting for folate and vitamin B6, but this association was attenuated after controlling for vitamin B12 (hazard ratio = 1.49; 95% confidence interval 0.91, 2.46). CONCLUSIONS: Low B-vitamin concentration may be a risk factor for decreased bone health, yet does not fully explain the relation between elevated homocysteine and hip fracture. Thus, homocysteine is not merely a marker for low B-vitamin status.
CONTEXT: Elevated homocysteine is a strong risk factor for osteoporotic fractures among elders, yet it may be a marker for low B-vitamin status. OBJECTIVE: Our objective was to examine the associations of plasma concentrations of folate, vitamin B12, vitamin B6, and homocysteine with bone loss and hip fracture risk in elderly men and women. DESIGN: This was a longitudinal follow-up study of the Framingham Osteoporosis Study. SETTING: Community dwelling residents of Framingham, MA, were included in the study. PARTICIPANTS: A total of 1002 men and women (mean age 75 yr) was included in the study. MAIN OUTCOME MEASURES: Baseline (1987-1989) blood samples were used to categorize participants into plasma B-vitamin (normal, low, deficient) and homocysteine (normal, high) groups. Femoral neck bone mineral density (BMD) measured at baseline and 4-yr follow-up was used to calculate annual percent BMD change. Incident hip fracture was assessed from baseline through 2003. RESULTS: Multivariable-adjusted mean bone loss was inversely associated with vitamin B6 (P for trend 0.01). Vitamins B12 and B6 were inversely associated with hip fracture risk (all P for trend < 0.05), yet associations were somewhat attenuated and not significant after controlling for baseline BMD, serum vitamin D, and homocysteine. Participants with high homocysteine (>14 micromol/liter) had approximately 70% higher hip fracture risk after adjusting for folate and vitamin B6, but this association was attenuated after controlling for vitamin B12 (hazard ratio = 1.49; 95% confidence interval 0.91, 2.46). CONCLUSIONS: Low B-vitamin concentration may be a risk factor for decreased bone health, yet does not fully explain the relation between elevated homocysteine and hip fracture. Thus, homocysteine is not merely a marker for low B-vitamin status.
Authors: M T Hannan; D T Felson; B Dawson-Hughes; K L Tucker; L A Cupples; P W Wilson; D P Kiel Journal: J Bone Miner Res Date: 2000-04 Impact factor: 6.741
Authors: R R McLean; M T Hannan; B E Epstein; M L Bouxsein; L A Cupples; J Murabito; D P Kiel Journal: Am J Epidemiol Date: 2000-04-01 Impact factor: 4.897
Authors: Clara Gram Gjesdal; Stein Emil Vollset; Per Magne Ueland; Helga Refsum; Haakon E Meyer; Grethe S Tell Journal: J Bone Miner Res Date: 2007-05 Impact factor: 6.741
Authors: Robert Clarke; Helga Refsum; Jacqueline Birks; John Grimley Evans; Carole Johnston; Paul Sherliker; Per M Ueland; Joern Schneede; Joseph McPartlin; Ebba Nexo; John M Scott Journal: Am J Clin Nutr Date: 2003-05 Impact factor: 7.045
Authors: Markus Herrmann; Johannes Schmidt; Natascha Umanskaya; Graziana Colaianni; Fuad Al Marrawi; Thomas Widmann; Alberta Zallone; Britt Wildemann; Wolfgang Herrmann Journal: Bone Date: 2007-06-21 Impact factor: 4.398
Authors: Nahid Yazdanpanah; M Carola Zillikens; Fernando Rivadeneira; Robert de Jong; Jan Lindemans; André G Uitterlinden; Huibert A P Pols; Joyce B J van Meurs Journal: Bone Date: 2007-08-17 Impact factor: 4.398
Authors: C Lewerin; H Nilsson-Ehle; S Jacobsson; H Johansson; V Sundh; M K Karlsson; Ö Ljunggren; M Lorentzon; J A Kanis; U H Lerner; S R Cummings; C Ohlsson; D Mellström Journal: Osteoporos Int Date: 2013-10-16 Impact factor: 4.507
Authors: Shivani Sahni; Kelsey M Mangano; Robert R McLean; Marian T Hannan; Douglas P Kiel Journal: Curr Osteoporos Rep Date: 2015-08 Impact factor: 5.096
Authors: Meryl S Leboff; Rupali Narweker; Andrea LaCroix; Lieling Wu; Rebecca Jackson; Jennifer Lee; Douglas C Bauer; Jane Cauley; Charles Kooperberg; Cora Lewis; Asha M Thomas; Steven Cummings Journal: J Clin Endocrinol Metab Date: 2009-01-27 Impact factor: 5.958
Authors: Erik D Swenson; Karen E Hansen; Andrea N Jones; Zhanhai Li; Brooke Baltz-Ward; Arthur A Schuna; Mary E Elliott Journal: Calcif Tissue Int Date: 2013-03-15 Impact factor: 4.333